Paladin Labs Inc.
Paladin Labs Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients | Immune System Suppression; Liver Transplant Rejection | Enrolling by invitation | Phase 4 | 2024-12-11 | NCT05655273 | |
| Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations | Chemically-Induced Disorders, Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, nervous system disorder, poisoning, toxic encephalopathy | Recruiting | Phase 4 | 2024-01-02 | NCT05089604 |